Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 16Thoracic 4Head & Neck 4Other solid neoplasm 3Gastrointestinal 3Breast 3Tumor-Agnostic 2Other neoplasm 2Dermatologic 2Sarcoma 1Other hematologic neoplasm 1Other 1Lymphoid 1CNS 1

Conditions

Neoplasms 1Adenocarcinoma 1

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Calcitriol × Tumor-Agnostic × Clear all
NCT00298545 2011-11-18

Effect of Vitamin D and Calcium on Genes in the Colon

Rockefeller University

Phase 1 Completed
10 enrolled
Tumor-Agnostic

Adenocarcinoma

NCT00055263 2009-07-28

A New Formulation of Calcitriol (DN-101) in Patients With Advanced Malignancies

Novacea

Phase 1 Completed
60 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡